Gelteq Limited (GELS) vs Sonoma Pharmaceuticals, Inc. (SNOA)

Gelteq Limited and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited and Sonoma Pharmaceuticals, Inc. are of similar size ($6.0M and $5.9M). Across the 9 metrics below, Gelteq Limited leads on 6 and Sonoma Pharmaceuticals, Inc. on 3.

Valuation

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S — 0.22 2.25
P/B n/m 0.74 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.19 12.29
EV/Sales n/m (0.01) 2.56
Earnings yield — (96.06%) (2.99%)
Free cash flow yield 0.00% (54.36%) 0.00%

Profitability

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Gross margin — 38.91% 53.94%
Operating margin — (6.41%) 0.00%
Net margin — (10.33%) 0.00%
Free cash flow margin 0.00% (12.11%) 0.00%
Return on equity 0.00% (42.52%) (0.40%)
Return on assets 0.00% (13.85%) (3.32%)
Return on invested capital 0.00% (69.96%) 0.00%

Growth

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 47.00% 10.01%
EPS growth (last fiscal year) (62.07%) 32.26% —
Revenue growth, 5-year CAGR — 0.95% 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.05
Current ratio 0.09 2.99 2.31
Net debt to EBITDA (0.91) 1.03 0.85

Dividend

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric GELS SNOA Drug Manufacturers Specialty & Generic median
Market cap 5.89m 5.96m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack